Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 26 of Context Therapeutics Inc.'s SEC filings and found 4 warrant series, 1 ATM program and 3 shelf registrations on file for CNTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 4, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
MCRBSeres Therapeutics, Inc.
AKTXAkari Therapeutics, Plc
QNTMQuantum BioPharma Ltd.
ACTUActuate Therapeutics Inc
KYNBKyntra Bio, Inc.
HEPAHepion Pharmaceuticals, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
ESLAEstrella Immunopharma, Inc.
PLURPluri Inc. Common Stock
IGCIGC Pharma, Inc.
COCPCocrystal Pharma, Inc.
JSPRJasper Therapeutics, Inc.
AEONAEON Biopharma, Inc.
ABOSAcumen Pharmaceuticals, Inc.
BOLTBolt Biotherapeutics, Inc.